HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+7.32%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.65B
AUM Growth
+$1.65B
(-3.7%)
Cap. Flow
-$96.8M
Cap. Flow
% of AUM
-5.88%
Top 10 Holdings %
Top 10 Hldgs %
56.48%
Holding
62
New
19
Increased
12
Reduced
10
Closed
20
Top Buys
| 1 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$105M |
| 2 |
Zimmer Biomet
ZBH
|
$92.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$65M |
| 4 |
DexCom
DXCM
|
$59.4M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$53.4M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$129M |
| 2 |
Edwards Lifesciences
EW
|
$115M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$108M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
$82.1M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$74.4M |
Sector Composition
| 1 | Healthcare | 71.96% |
| 2 | Financials | 0% |
| 3 | Industrials | 0% |
| 4 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KND
26
DELISTED
Kindred Healthcare
KND
| $16.7M | 1.01% |
+1,400,000
| New | +$16.7M |
|
27
Biogen
BIIB
$20.8B
| $14.4M | 0.88% |
+47,090
| New | +$14.4M |
|
28
Merck
MRK
$210B
| $12.4M | 0.76% |
+235,440
| New | +$12.4M |
|
|
ALXN
29
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $11.4M | 0.69% |
59,890
-390,110
| -87% | -$74.4M |
|
30
AbbVie
ABBV
$374B
| $11.2M | 0.68% |
+188,600
| New | +$11.2M |
|
|
SPNE
31
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $10.4M | 0.63% |
604,000
+104,000
| +21% | +$1.79M |
|
32
Arbutus Biopharma
ABUS
$753M
| $9.74M | 0.59% |
2,189,200
+39,200
| +2% | +$174K |
|
|
33
Edwards Lifesciences
EW
$47.7B
| $7.56M | 0.46% |
95,760
-679,240
| -88% | -$115M |
|
34
Natera
NTRA
$23B
| $2.97M | 0.18% |
275,000
+20,000
| +8% | +$216K |
|
|
HSTO
35
DELISTED
Histogen Inc. Common Stock
HSTO
| $2.96M | 0.18% |
1,026,900
+18,400
| +2% | +$53K |
|
36
Tandem Diabetes Care
TNDM
$834M
| $2.3M | 0.14% |
195,112
-30,688
| -14% | -$362K |
|
37
Pacira BioSciences
PCRX
$1.22B
| $1.65M | 0.1% |
+21,500
| New | +$1.65M |
|
38
UnitedHealth
UNH
$279B
| $959K | 0.06% |
+8,150
| New | +$959K |
|
39
HCA Healthcare
HCA
$95.4B
| $756K | 0.05% |
11,180
-563,820
| -98% | -$38.1M |
|
40
Align Technology
ALGN
$9.59B
| $527K | 0.03% |
+8,000
| New | +$527K |
|
41
Amgen
AMGN
$153B
| $365K | 0.02% |
+2,250
| New | +$365K |
|
42
Zoetis
ZTS
$67.6B
| $288K | 0.02% |
+6,000
| New | +$288K |
|
|
ANAC
43
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| – | – |
-125,000
| Closed | -$14.7M |
|
|
OREX
44
DELISTED
Orexigen Therapeutics, Inc.
OREX
| – | – |
-425,000
| Closed | -$897K |
|
|
RLYP
45
DELISTED
RELYPSA INC COM
RLYP
| – | – |
-829,041
| Closed | -$15.3M |
|
|
TMH
46
DELISTED
Team Health Holdings Inc
TMH
| – | – |
-450,000
| Closed | -$24.3M |
|
|
ALR
47
DELISTED
Alere Inc
ALR
| – | – |
-400,000
| Closed | -$19.3M |
|
|
CEMP
48
DELISTED
Cempra, Inc.
CEMP
| – | – |
-350,000
| Closed | -$9.74M |
|
|
ABCO
49
DELISTED
Advisory Board Co/The
ABCO
| – | – |
-338,252
| Closed | -$15.4M |
|
|
AET
50
DELISTED
Aetna Inc
AET
| – | – |
-650,000
| Closed | -$71.1M |
|